Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
INSP · against 588 other Healthcare companies listed in US-listed
Ranked #62 of 589 · scores higher than 88% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 70–79, including INSP · Click a bar to see the companies
Mainly thanks to its earnings yield and free cash flow yield, which are stronger than most Healthcare peers.
| Metric | INSP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 7.3% | -4.3% | 94% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 4.8% | -0.8% | 69% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 6.5% | -2.3% | 88% | 20% | |
| Book yieldHigher is better · 587 reported | 46.1% | 25.9% | 71% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 60 | 89.7B USD | 76 | 50 | |
| 60 | 528M USD | 76 | 58 | |
| 62 | 2.3B USD | 75 | 74 | |
| 62 | 38.9B USD | 75 | 56 | |
| 62 | 1.8B USD | 75 | 80 | |
| 62 | 107M USD | 75 | 31 | |
| 62 | 2.7B USD | 75 | 84 | |
| 62 | 464M USD | 75 | 53 | |
| 62 | 646M USD | 75 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score